Manufacturer's investigation conclusion: a specific cause for the reported events (bleeding, cardiogenic shock) and subsequent patient outcome, as well as a direct correlation to heartmate 3 left ventricular assist system (lvas), serial number (b)(6) , could not be conclusively be determined through this evaluation.The heartmate 3 lvas instructions for use (ifu) lists bleeding and death as adverse events that may be associated with the use of the heartmate 3 lvas.The ifu also provides information regarding the recommended anticoagulation regimen and international normalized ratio values as well as suggested anticoagulation modifications in the event that there is a risk of bleeding.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specification.No further information was provided.The manufacturer is closing the file on this event.
|